Pepgen Inc.

Biotechnology • Healthcare • Boston, MA, United States • PEPG (NMS)

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to treat duchenne muscular dystrophy (DMD) patients that are amenable to an exon 51-skipping approach; PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and PGN-EDO53, which is in preclinical trial to treat duchenne muscular dystrophy. The company was founded in 2018 and is based in Boston, Massachusetts.

781 797 0979 321 Harrison Avenue, Boston, MA 02118, United States

Stock Performance (90 Days)

Data through Dec 24, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

PepGen’s stock up 120% on DM1 trial success - Clinical Trials Arena

Clinical Trials Arena • Sep 26

PepGen (NASDAQ:PEPG) Reaches New 12-Month High - What's Next? - MarketBeat

MarketBeat • Jan 2

How Much Upside is Left in PepGen (PEPG)? Wall Street Analysts Think 75.44% - Yahoo Finance

Yahoo Finance • Dec 10

$PEPG stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

Quiver Quantitative • Dec 24

PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - Business Wire

Business Wire • Nov 12

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has PepGen Inc. had layoffs?

No layoff events have been recorded for PepGen Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does PepGen Inc. have?

PepGen Inc. has approximately 57 employees.

What industry is PepGen Inc. in?

PepGen Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is PepGen Inc. a publicly traded company?

Yes, PepGen Inc. is publicly traded under the ticker symbol PEPG on the NMS. The company has a market capitalization of approximately $0.40 billion.

Where is PepGen Inc. headquartered?

PepGen Inc. is headquartered in Boston, MA, United States at 321 Harrison Avenue, Boston, MA 02118, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.